AprilBio Co.,Ltd. (397030.KQ) — Stock Score Summary

AprilBio Co.,Ltd. (397030.KQ) has a MoatMap StockRank of 27/100 based on Quality (43/100), Value (35/100), and Momentum (37/100) factor scores. The current signal is SELL.

AprilBio Co.,Ltd. develops long-acting type biobetter and antibody biologics. The company develops antibody drugs, double antibodies, long-acting antibody drugs, long-acting protein drugs, and ADC-applied antibodies.

Key Financial Metrics

Price$28.57
Market Cap$621M
P/E (Forward)-42.77
Price/Book10.46
Return on Equity-10.6%
Return on Invested Capital-9.4%
Debt/Equity0.45
Gross Margin96.8%
Operating Margin-302.3%
Revenue Growth-66.6%
Free Cash Flow$-4K

AprilBio Co.,Ltd. operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is AprilBio Co.,Ltd.’s (397030.KQ) StockRank?
MoatMap’s StockRank for AprilBio Co.,Ltd. (397030.KQ) is 27/100, with a Sell signal. It is a composite of Quality (43), Value (35), and Momentum (37) factor ranks across MoatMap’s 19,000+ stock universe.
Does AprilBio Co.,Ltd. have an economic moat?
AprilBio Co.,Ltd. (397030.KQ) has a Quality factor score of 43/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is AprilBio Co.,Ltd. a buy, hold, or sell?
MoatMap’s current signal for AprilBio Co.,Ltd. (397030.KQ) is Sell, based on a StockRank of 27/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is AprilBio Co.,Ltd. in?
AprilBio Co.,Ltd. (397030.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks397030.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock